TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18082522

Group type: EXPERIMENTAL
Intervention: Low amount/moderate intensity exercise (equivalent to walking approximately 19 km/week)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Low amount/vigorous intensity exercise (equivalent to jogging approximately 19 km/week)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: High amount/vigorous intensity exercise (equivalent to jogging approximately 32 km/week)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 171

Group type: COMPARATOR
Intervention: Inactive controls
Number of subjects: 171
Study: 16253070

Group type: EXPERIMENTAL
Intervention: 400 mg of norfloxacin
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Overall infection rate after FC
Number of subjects: 234
Study: 12693324

Group type: EXPERIMENTAL
Intervention: Combined therapy with Praziquantel (25-50 mg/kg for 14 days)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Surgical treatment only
Number of subjects: 136
Study: 9949745

Group type: EXPERIMENTAL
Intervention: Reach for Health Community Youth Service (CYS) program
Number of subjects: 1061

Group type: EXPERIMENTAL
Intervention: Reach for Health classroom curriculum only
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Control condition (students at the other school)
Number of subjects: 1061
Study: 7588990

Group type: EXPERIMENTAL
Intervention: Intranasal Apomorphine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Subcutaneous Apomorphine
Number of subjects: 7
Study: 2134545

Group type: EXPERIMENTAL
Intervention: Low-energy cardiovasoprotective (CVP) diet (Group A)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Low-energy usual diet (Group B)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Optimal-energy CVP diet (Group C)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Optimal-energy, usual pre-experimental diet (Group D)
Number of subjects: 416
Study: 6958479

Group type: EXPERIMENTAL
Intervention: 4 divided doses of BDP
Number of subjects: 29

Group type: COMPARATOR
Intervention: 2 doses of BDP
Number of subjects: 29
Study: 31992545

Group type: EXPERIMENTAL
Intervention: Swedish Knee Control programme and standard running warm-up before every training session and match during the season
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Swedish Knee Control programme
Number of subjects: 471

Group type: COMPARATOR
Intervention: Control group (usual training)
Number of subjects: 471
Study: 31729976

Group type: EXPERIMENTAL
Intervention: Modified catheter (Group C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional tracheal intubation without endotracheal anesthesia (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional tracheal intubation with endotracheal anesthesia (Group B)
Number of subjects: 90
Study: 28801940

Group type: EXPERIMENTAL
Intervention: 3-month lifestyle (diet and exercise) weight loss intervention
Number of subjects: 70
Study: 26441396

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) defined as post‐tetanic‐count (PTC) of 0‐1
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard neuromuscular blockade defined as bolus administrations
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB)
Number of subjects: 128
Study: 23418444

Group type: EXPERIMENTAL
Intervention: Minimal intensity physical activity (walking and standing)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sitting regime
Number of subjects: 18

Group type: COMPARATOR
Intervention: Exercise regime (vigorous exercise)
Number of subjects: 18
Study: 21548919

Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioral multidisciplinary lifestyle treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Advice on physical activity and nutrition (Control)
Number of subjects: 80
Study: 19497458

Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 165

Group type: COMPARATOR
Intervention: No-intervention
Number of subjects: 165
Study: 17695877

Group type: EXPERIMENTAL
Intervention: Glazed surfaces
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Polished surfaces
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Brushing on glazed surfaces
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Brushing on polished surfaces
Number of subjects: 2

Group type: COMPARATOR
Intervention: Comparison between glazed and polished surfaces after 1 hour
Number of subjects: 2
Study: 16682575

Group type: EXPERIMENTAL
Intervention: Electronic medical record alerts for coprescription of warfarin and interacting medications (acetaminophen, nonsteroidal anti‐inflammatory medications, fluconazole, metronidazole, sulfamethoxazole)
Number of subjects: 9910

Group type: COMPARATOR
Intervention: Group academic detailing
Number of subjects: 9910
Study: 15173406

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (weekly home visits from birth to 8 weeks and from 7 to 24 months)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (LBW infants without intervention)
Number of subjects: 140
Study: 10739153

Group type: EXPERIMENTAL
Intervention: In-shoe plantar pressure measurement system
Number of subjects: 14
Study: 8737627

Group type: COMPARATOR
Intervention: 0.250 mg brotizolam
Number of subjects: 49

Group type: COMPARATOR
Intervention: 0.125 mg brotizolam
Number of subjects: 49

Group type: COMPARATOR
Intervention: Both treatments (0.125 mg and 0.250 mg brotizolam)
Number of subjects: 49
Study: 1560699

Group type: EXPERIMENTAL
Intervention: Topical 40% idoxuridine in dimethyl sulfoxide (IDU)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Oral acyclovir (ACV)
Number of subjects: 171
Study: 3840882

Group type: EXPERIMENTAL
Intervention: Intravenous furosemide (2 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Inhaled atropine sulfate (0.05 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Inhaled isoproterenol (0.2 cc, 1:200)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31868850

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 39

Group type: COMPARATOR
Intervention: LASEK
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study: 30445893

Group type: EXPERIMENTAL
Intervention: Video-assisted patient education
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 107
Study: 28012977

Group type: EXPERIMENTAL
Intervention: One-stage IBBR with ADM
Number of subjects: 142

Group type: COMPARATOR
Intervention: Two-stage IBBR
Number of subjects: 142

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 142
Study: 25887231

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pelvic floor muscle training
Number of subjects: 0
Study: 23075634

Group type: EXPERIMENTAL
Intervention: Alfentanil and morphine (Group AM)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Fentanyl (Group F)
Number of subjects: 212
Study: 21593417

Group type: EXPERIMENTAL
Intervention: Line drawings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Color photographs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Line drawings with long contours removed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Line drawings with short contours removed
Number of subjects: 0
Study: 19188926

Group type: EXPERIMENTAL
Intervention: Ephedra and caffeine (E+C)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 17713162

Group type: EXPERIMENTAL
Intervention: TMC125 100 mg twice daily coadministered with DRV/r 600/100 mg twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: TMC125 200 mg twice daily coadministered with DRV/r 600/100 mg twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: DRV/r 600/100 mg twice daily
Number of subjects: 32
Study: 15053373

Group type: COMPARATOR
Intervention: Salbutamol alone (0.03 ml/kg/dose)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combined nebulization of Salbutamol (0.03 ml/kg/dose) and Ipratropium bromide (250 microgm/dose for three doses)
Number of subjects: 50
Study: 11575732

Group type: EXPERIMENTAL
Intervention: Treatment algorithms for treatment-resistant depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Texas Medication Algorithm Project
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequenced Treatment Alternatives to Relieve Depression
Number of subjects: 0
Study: 9337491

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment package including cognitive correction, problem-solving training, social skills training, and relapse prevention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 29
Study: 7946368

Group type: COMPARATOR
Intervention: Plain 0.5% bupivacaine with 1:200,000 epinephrine (Group 1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Liposomal 0.5% bupivacaine (Group 2)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 3035003

Group type: EXPERIMENTAL
Intervention: Anti-D immunoglobulin injections at 28th and 34th weeks of pregnancy
Number of subjects: 1988

Group type: COMPARATOR
Intervention: Control group without treatment
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Antepartum treatment
Number of subjects: 1988

Group type: COMPARATOR
Intervention: Kleihauer tests at 29th week of pregnancy
Number of subjects: 1988

Group type: COMPARATOR
Intervention: Kleihauer tests at 34th week of pregnancy
Number of subjects: 1988
Study: 28903790

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Informational Pamphlet (IP)
Number of subjects: 10
Study: 28711117

Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Progressive Muscle Relaxation (MB‐PMR)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Thought Wandering Control (TWC)
Number of subjects: 81
Study: 25596910

Group type: EXPERIMENTAL
Intervention: CONSORT dosing (follitropin alfa starting dose determined by the CONSORT calculator)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard dosing (150 IU of follitropin alfa)
Number of subjects: 200
Study: 24285276

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 1950

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1950

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 1950

Group type: EXPERIMENTAL
Intervention: Older age at randomization
Number of subjects: 1950

Group type: EXPERIMENTAL
Intervention: Lower bone mineral density
Number of subjects: 1950

Group type: EXPERIMENTAL
Intervention: Inactivity
Number of subjects: 1950
Study: 21955647

Group type: EXPERIMENTAL
Intervention: Soy nuts, soy milk, tempeh
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 50 mg genistein
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 20 mg pure S-(−)equol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Soy infant formula and soy germ isoflavone supplement
Number of subjects: 7

Group type: COMPARATOR
Intervention: Soy-containing diets
Number of subjects: 7
Study: 18779360

Group type: EXPERIMENTAL
Intervention: AS plus AQ (n = 88)
Number of subjects: 103

Group type: COMPARATOR
Intervention: AQ only (n = 15)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study: 16574882

Group type: EXPERIMENTAL
Intervention: IBS women
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: IBS men
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy women
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy men
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: IBS and control women
Number of subjects: 58
Study: 14977339

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.25-0.5 microg kg(‐1) min(‐1), n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fentanyl (2-5 microg kg(‐1), n = 16)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remifentanil and Fentanyl
Number of subjects: 32
Study: 10707788

Group type: EXPERIMENTAL
Intervention: Synthetic epitope for My‐La CTL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic epitopes
Number of subjects: 0
Study: 9446300

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Infrared pulsed laser therapy
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Niacin electrophoresis
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 109

Group type: COMPARATOR
Intervention: Laser imitation (control group)
Number of subjects: 109
Study: 1526696

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg and 20 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 3886706

Group type: EXPERIMENTAL
Intervention: tolmetin 1,200 mg/d for three weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo for three weeks
Number of subjects: 26
Study: 29137895

Group type: EXPERIMENTAL
Intervention: Four-kallikrein panel (total, free, and intact PSA and hK2)
Number of subjects: 4861

Group type: EXPERIMENTAL
Intervention: Four-kallikrein panel plus β-microseminoprotein (MSP)
Number of subjects: 4861

Group type: COMPARATOR
Intervention: Total PSA and age
Number of subjects: 4861
Study: 27809403

Group type: EXPERIMENTAL
Intervention: Global evaluation after 8 hours of continuous duty
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Analytical evaluation after 8 hours of continuous duty
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Global evaluation after sufficient sleep
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Analytical evaluation after sufficient sleep
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Global evaluation on day 2 (after sleep)
Number of subjects: 4
Study: 28588915

Group type: EXPERIMENTAL
Intervention: Training programme for associate clinicians in emergency obstetric and neonatal care
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Training programme for associate clinicians
Number of subjects: 46
Study: 25517279

Group type: EXPERIMENTAL
Intervention: Grape powder (500 mg of polyphenols/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 23332908

Group type: COMPARATOR
Intervention: Asymptomatic subjects
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Subjects with mechanical low back pain
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Subjects with symptomatic spinal stenosis
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Subjects with symptomatic spinal stenosis (severe)
Number of subjects: 35
Study: 20447621

Group type: EXPERIMENTAL
Intervention: NADH 20mg
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 18983652

Group type: EXPERIMENTAL
Intervention: Seven-session group training combined with three individual counselling sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no care or care as usual)
Number of subjects: 0
Study: 16887155

Group type: EXPERIMENTAL
Intervention: Orange-based drinks (three types with varying sweetness intensity)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Orange peach drink (highest sugar content)
Number of subjects: 68
Study: 14529097

Group type: EXPERIMENTAL
Intervention: Montelukast (5-mg chewable tablet once daily)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Cromolyn (two puffs 4 times daily)
Number of subjects: 333
Study: 10634360

Group type: EXPERIMENTAL
Intervention: Testosterone (300 mg, im, every 3 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NRTI treatment without protease inhibitor
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NRTI treatment with protease inhibitor
Number of subjects: 50
Study: 9336129

Group type: COMPARATOR
Intervention: Standard radiation therapy with 60 Gy at 2.0 Gy per day (STD RT)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin 100 mg/m2 days 1 and 29 with vinblastine 5 mg/m2 weekly for 5 weeks followed by 60 Gy at 2.0 Gy per day (CT + RT)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy with 69.6 Gy at 1.2 Gy b.i.d. (HFX RT)
Number of subjects: 458
Study: 8441078

Group type: EXPERIMENTAL
Intervention: Bimanual palpation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ballottement palpation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Palpation from above
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nixon's percussion method
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Castell's percussion method
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Barkun et al.'s percussion method
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of tests (palpation or percussion)
Number of subjects: 27
Study: 2876325

Group type: COMPARATOR
Intervention: Pneumococcal capsular polysaccharide vaccines
Number of subjects: 3
Study: 28920542

Group type: EXPERIMENTAL
Intervention: Brief risk-reducing Motivational Interviewing (MI) counselling intervention, n=74
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group, n=99
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Brief risk-reducing Motivational Interviewing (MI) counselling intervention
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 173
Study: 27327441

Group type: EXPERIMENTAL
Intervention: Spironolactone (50 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Renal denervation (RDN)
Number of subjects: 24
Study: 24218527

Group type: EXPERIMENTAL
Intervention: IFNB1b 250 μg subcutaneously every other day
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 22354108

Group type: EXPERIMENTAL
Intervention: Dynamic wrist-hand orthosis (WHO)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Manual-assisted therapy (MAT)
Number of subjects: 19
Study: 20138609

Group type: EXPERIMENTAL
Intervention: TCMF IOL
Number of subjects: 248

Group type: COMPARATOR
Intervention: CEMN IOL
Number of subjects: 248
Study: 18208849

Group type: EXPERIMENTAL
Intervention: Perfusion-cardiac magnetic resonance (perfusion-CMR) at a dose of 0.1 mmol/kg Gd-DTPA-BMA
Number of subjects: 234

Group type: COMPARATOR
Intervention: Single-photon emission computed tomography (SPECT)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Perfusion-cardiac magnetic resonance (perfusion-CMR)
Number of subjects: 234
Study: 15931612

Group type: EXPERIMENTAL
Intervention: Beef supplementation (0.6 g-protein/kg per day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Soy-based texturized vegetable protein foods (VEG group)
Number of subjects: 21
Study: 12839376

Group type: EXPERIMENTAL
Intervention: Azathioprine (2.5 mg/Kg/day; Group A, n = 12)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sulfasalazine (6 g/day; Group B, n = 13)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Azathioprine (Group A)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sulfasalazine (Group B)
Number of subjects: 25
Study: 12458303

Group type: EXPERIMENTAL
Intervention: Enhanced care for uninsured patients
Number of subjects: 383

Group type: COMPARATOR
Intervention: Usual care for uninsured patients
Number of subjects: 383

Group type: COMPARATOR
Intervention: Usual care for insured patients
Number of subjects: 383
Study: 10401919

Group type: EXPERIMENTAL
Intervention: Regular cigarette containing 290 microg/kg body weight of tetrahydrocannabinol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular cigarette (placebo)
Number of subjects: 60
Study: 7473798

Group type: EXPERIMENTAL
Intervention: TRH (0.2 mg/kg intravenous bolus followed by 0.2 mg/kg/h infusion over 6 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle (equal volume physiological saline) placebo
Number of subjects: 20
Study: 2075851

Group type: EXPERIMENTAL
Intervention: Linear methadone detoxification procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse exponential methadone reduction curve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose addicts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose addicts
Number of subjects: 0
Study: 7053242

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 150 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 500 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1500 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Free (unbound) ceftriaxone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Free ceftriaxone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (all doses)
Number of subjects: 6
Study: 6368591

Group type: EXPERIMENTAL
Intervention: High dose chenodiol (750 mg/d)
Number of subjects: 916

Group type: EXPERIMENTAL
Intervention: Low dose chenodiol (375 mg/d)
Number of subjects: 916

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 916
Study: 31690491

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous exercise (MCE)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HIE)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 17
Study: 30373651

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 816

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 816
Study: 27372525

Group type: EXPERIMENTAL
Intervention: Group Intervention (GI)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Individual Intervention (II)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Internal Control (IC)
Number of subjects: 182

Group type: COMPARATOR
Intervention: External Control (EC)
Number of subjects: 182
Study: 24795201

Group type: EXPERIMENTAL
Intervention: Sofosbuvir-ribavirin for 12 weeks in HCV genotype 2 infection
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sofosbuvir-ribavirin for 24 weeks in HCV genotype 3 infection
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sofosbuvir-ribavirin in HCV genotype 3 infection without cirrhosis
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Sofosbuvir-ribavirin in HCV genotype 3 infection with cirrhosis
Number of subjects: 419